Skip to main content

Giving Full Measure to Countermeasures Addressing Problems in the DoD Program to Develop Medical Countermeasures Against Biological Warfare Agents (2004) / Chapter Skim
Currently Skimming:

Appendix B: Agendas for Information-Gathering Meetings
Pages 117-126

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 117...
... Introductory Remarks Leslie Benet, Ph.D., Chair, Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents Introductions by Committee Members and Meeting Attendees 1:30 Sponsor Presentation on the Study Charge Carol Linden, Ph.D., Director, Medical Chemical and Biological Defense Research Program, U.S. Army Medical Research and Materiel Command Congressional Comment on the Study Charge Mr.
Read the entire page →
From page 118...
... Military Stanley Lemon, M.D., Chair, IOM Committee on a Strategy for Minimizing the Impact of Naturally Occurring Infectious Diseases of Military Importance: Vaccine Issues in the U.S. Military Discussion
Read the entire page →
From page 119...
... Army Medical Research and Materiel Command (USAMRMC) Carol Linden, Ph.D., Director, Medical Chemical and Biological Defense Research Program, USAMRMC 10:30 Break 10:45 Chemical Biological Medical Systems (CBMS)
Read the entire page →
From page 120...
... John Carney, Ph.D., Unconventional Pathogen Countermeasures Program 1:45 Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) BG Stephen Reeves, Program Executive Officer, Chemical and Biological Defense 2:15 Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear (JRO-CBRN)
Read the entire page →
From page 121...
... Breakfast 9:30 Introductory Remarks Leslie Z Benet, Ph.D., Chair, Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents 9:45 Current and Planned Activities of the National Institute of Allergy and Infectious Diseases (NIAID)
Read the entire page →
From page 122...
... , DoD Virginia Johnson, Ph.D., Deputy Product Development Manager, DynPort Vaccine Company LLC Carol Linden, Ph.D., Director, Medical Chemical and Biological Defense Research Program, USAMRMC, DoD John McCormick, M.D., Orphan Products Development, FDA Andrea Meyerhoff, M.D., Director, Counterterrorism Programs, Office of the Commissioner, FDA Dianne Murphy, M.D., Director, Office of Counterterrorism and Pediatric Drug Development, Center for Drug Evaluation and Research, FDA Jerald Sadoff, M.D., Washington, DC 4:30 Adjourn Open Session Tuesday, March 18, 2003 8:00 a.m. Breakfast 8:30 Roundtable Discussion: I
Read the entire page →
From page 123...
... , DoD Raymond Keifer, Ph.D., Senior Director Manufacturing, BioReliance Corporation Michael Langford, D.V.M., Ph.D., Senior Vice President and Chief Scientific Officer, DynPort Vaccine Company, LLC Frank Lee, Ph.D., President and CEO, engeneOS Brad Leissa, M.D., Office of Counterterrorism and Pediatric Drug Development, Center for Drug Evaluation and Research, FDA John McCormick, M.D., Orphan Products Development, FDA Dennis Panicali, Ph.D., Chief Scientific Officer, Therion Biologics Jerald Sadoff, M.D., Washington, DC Peter Young, M.B.A., President and CEO, AlphaVax Philip Youngman, Ph.D., Vice President of Discovery Biology, Elitra Pharmaceuticals 11:45 Adjourn Open Session
Read the entire page →
From page 124...
... Breakfast 9:30 Introductory Remarks Leslie Z Benet, Ph.D., Chair, Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents 9:45 Availability of Biocontainment Facilities Needed to Support Research and Development of Medical Countermeasures to Biological Warfare Agents Gerald Parker, M.S., D.V.M., Ph.D., Colonel, Veterinary Corps, Assistant Deputy for Research and Development, USAMRMC Discussion 11:15 Break 11:30 Role of the Assistant Secretary of Defense for Health Affairs in DoD Efforts Toward Accelerating the Development and Licensure of Medical Countermeasures Against Biological Warfare Agents William Winkenwerder, Jr., M.D., M.B.A., Assistant Secretary of Defense for Health Affairs Discussion 12:30 p.m.
Read the entire page →
From page 125...
... Introductory Remarks Leslie Z Benet, Ph.D., Chair, Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents 2:00 Perspectives on Liability Issues Related to Biowarfare Countermeasures Mr.
Read the entire page →

Key Terms

  • biological warfare
  • warfare agents
  • biological defense
  • dynport vaccine
  • remarks leslie

  • vaccine company
  • army medical
  • materiel command
  • infectious diseases
  • introductory remarks

  • biological medical
  • medical chemical
  • chief scientific
  • company llc
  • scientific officer

  • col david
  • carol linden
  • drug evaluation
  • defense research
  • david danley

  • leslie z
  • leslie benet
  • john mccormick
  • program executive
  • drug development

  • health affairs
  • jerald sadoff
  • products development
  • z benet
  • orphan products


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.